Clinical utility of a blood-based EGFR mutation test in patients receiving first-line erlotinib therapy in the ENSURE, FASTACT-2, and ASPIRATION studies

Autor: Wu, Yi-Long, Lee, Victor, Liam, Chong-Kin, Lu, Shun, Park, Keunchil, Srimuninnimit, Vichien, Wang, Jie, Zhou, Caicun, Appius, Anita, Button, Peter, Hooper, Gregory, Palma, John F., Schulze, Katja, Scudder, Sidney, Shames, David S., Yin, Anny-Yue, Zhang, Guili, Mok, Tony
Zdroj: In Lung Cancer December 2018 126:1-8
Databáze: ScienceDirect